Cargando…
Risk of Osteoporotic Fractures after Thyroid-stimulating Hormone Suppression Therapy in Patients with Thyroid Cancer
BACKGROUND: The effects of subclinical hyperthyroidism on fracture risk induced by thyroid-stimulating hormone (TSH) suppression therapy in patients with thyroid cancer still remains controversial. We performed a meta-analysis and systematic review to evaluate the effects of TSH suppression therapy...
Autores principales: | Lee, Youjin, Yoon, Byung-Ho, Lee, Seeyoun, Chung, Youn Kyung, Lee, Young-Kyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Bone and Mineral Research
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416149/ https://www.ncbi.nlm.nih.gov/pubmed/30899724 http://dx.doi.org/10.11005/jbm.2019.26.1.45 |
Ejemplares similares
-
Influence of Thyroid-stimulating Hormone Suppression Therapy on Bone Mineral Density in Patients with Differentiated Thyroid Cancer: A Meta-analysis
por: Yoon, Byung-Ho, et al.
Publicado: (2019) -
Epidemiology of Osteoporosis and Osteoporotic Fractures in South Korea
por: Lee, Young-Kyun, et al.
Publicado: (2013) -
Osteoporotic Fractures of the Spine, Hip, and Other Locations after Adjuvant Endocrine Therapy with Aromatase Inhibitors in Breast Cancer Patients: a Meta-analysis
por: Lee, Young-Kyun, et al.
Publicado: (2020) -
Effect of withdrawal of thyroid hormones versus administration of recombinant human thyroid-stimulating hormone on renal function in thyroid cancer patients
por: An, Young-Sil, et al.
Publicado: (2023) -
Risk of Osteoporotic Fracture in Patients with Breast Cancer: Meta-Analysis
por: Lee, Seeyoun, et al.
Publicado: (2020)